HTA:NYE-Healthcare Trust of America, Inc (USD)

COMMON STOCK | REIT—Healthcare Facilities | NYE

Last Closing Price

USD 21.94

Change

0.00 (0.00)%

Market Cap

USD 4.75B

Volume

1.42M

Average Target Price

USD 30.70 (+39.93%)
Average Analyst Rating

Verdict

Fundamental Analysis

Verdict

About

Healthcare Trust of America, Inc. (NYSE: HTA) is the largest dedicated owner and operator of MOBs in the United States, comprising approximately 24.8 million square feet of GLA, with $7.3 billion invested primarily in MOBs. HTA provides real estate infrastructure for the integrated delivery of healthcare services in highly-desirable locations. Investments are targeted to build critical mass in 20 to 25 leading gateway markets that generally have leading university and medical institutions, which translates to superior demographics, high-quality graduates, intellectual talent and job growth. The strategic markets HTA invests in support a strong, long-term demand for quality medical office space. HTA utilizes an integrated asset management platform consisting of on-site leasing, property management, engineering and building services, and development capabilities to create complete, state of the art facilities in each market. This drives efficiencies, strong tenant and health system relationships, and strategic partnerships that result in high levels of tenant retention, rental growth and long-term value creation. Headquartered in Scottsdale, Arizona, HTA has developed a national brand with dedicated relationships at the local level. Founded in 2006 and listed on the New York Stock Exchange in 2012, HTA has produced attractive returns for its stockholders that have outperformed the S&P 500 and US REIT index.

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2020-04-05 )

Largest Industry Peers for REIT—Healthcare Facilities

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
WELL Welltower Inc

N/A

USD15.30B 15.01 N/A
VTR Ventas, Inc

N/A

USD8.40B 22.91 N/A
MPW Medical Properties Trust, Inc

N/A

USD7.50B 20.32 N/A
OHI Omega Healthcare Investors, In..

N/A

USD5.47B 17.68 N/A
HR Healthcare Realty Trust Incorp..

N/A

USD3.41B 89.79 N/A
DOC Physicians Realty Trust

N/A

USD2.60B 36.65 N/A
NHI National Health Investors, Inc

N/A

USD1.68B 13.49 N/A
GEO The GEO Group, Inc

N/A

USD1.31B 8.69 N/A
UHT Universal Health Realty Income..

N/A

USD1.26B 68.11 N/A
LTC LTC Properties, Inc

N/A

USD1.08B 15.30 N/A

ETFs Containing HTA

Symbol Name Weight Mer Price(Change) Market Cap

N/A

Market Performance

  Market Performance vs.
Industry/Classification (REIT—Healthcare Facilities)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -27.54% 79% C+ 54% F
Dividend Return 1.04% 31% F 59% F
Total Return -26.50% 79% C+ 56% F
Trailing 12 Months  
Capital Gain -23.45% 62% D- 56% F
Dividend Return 4.38% 23% F 79% C+
Total Return -19.07% 62% D- 58% F
Trailing 5 Years  
Capital Gain -22.66% 70% C- 52% F
Dividend Return 22.47% 30% F 76% C
Total Return -0.19% 70% C- 57% F
Average Annual (5 Year Horizon)  
Capital Gain 3.86% 42% F 56% F
Dividend Return 4.55% 33% F 77% C+
Total Return 8.41% 33% F 62% D-
Risk Return Profile  
Volatility (Standard Deviation) 14.82% 83% B 54% F
Risk Adjusted Return 56.72% 42% F 61% D-
Market Capitalization 4.75B 71% C- 80% B-
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(REIT—Healthcare Facilities)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 156.36 14% F 3% F
Price/Book Ratio N/A N/A N/A N/A N/A
Price / Cash Flow Ratio 13.97 36% F 20% F
EV/EBITDA N/A N/A N/A N/A N/A
Management Effectiveness  
Return on Equity 0.91% 7% F 25% F
Return on Invested Capital 2.49% 14% F 26% F
Return on Assets 1.45% 7% F 32% F
Debt to Equity Ratio 81.89% 79% C+ 43% F
Technical Ratios  
Short Ratio 6.09 8% F 11% F
Short Percent 7.56% 8% F 48% F
Beta 0.40 64% D 81% B-
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

Low debt

The company is less leveraged than its peers ,, and is among the top quartile, which makes it more flexible. However, do check the news and look at its sector. Sometimes this is low because the company is not growing and has no growth potential.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Poor return on equity

The company management has delivered below median return on equity in the most recent 4 quarters compared to its peers.

Poor capital utilization

The company management has delivered below median return on invested capital in the most recent 4 quarters compared to its peers.

Poor return on assets

The company management has delivered below median return on assets in the most recent 4 quarters compared to its peers.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector